[Continuous Glucose Monitoring: A Paradigm Shift]. [PDF]
García Solans JR.
europepmc +1 more source
[Indicators of diabetes mellitus after liraglutide, sitagliptin/metformin, linagliptin, and sitagliptin]. [PDF]
Atonal-Flores B +2 more
europepmc +1 more source
La glucemia mantenida entre 110-125 mg/dl ¿es un factor de riesgo de desarrollo de diabetes?
Guadalupe Alemán-Vega +3 more
semanticscholar +1 more source
[Diabetic neuropathy and its relationship with quality of life in patients with type 2 diabetes]. [PDF]
Arévalo Ramírez JR +5 more
europepmc +1 more source
[Analysis of pancreatic function in pediatric patients with COVID-19]. [PDF]
Molina Gutiérrez MÁ +5 more
europepmc +1 more source
Parámetros de variabilidad glucémica de la monitorización continua de glucosa como predictores de diabetes: evaluación prospectiva en una población general sin diabetes. [PDF]
Valle Rodríguez A +4 more
europepmc +1 more source
Sobre el tratamiento eficaz de la insulina en la diabetes [PDF]
Luis R. Grote
core +1 more source
[Continuous glucose monitoring devices in people over 65 years: literature review]. [PDF]
Guisado-Barral B +7 more
europepmc +1 more source
[Clinical behavior of SARS-CoV-2 infection (COVID-19) in patients with type-2 diabetes mellitus in a respiratory care unit]. [PDF]
Hernández-Solís A +2 more
europepmc +1 more source
[Professional Pharmaceutical Care Services. A case report]. [PDF]
Dévora Gutiérrez S +5 more
europepmc +1 more source

